Despite a challenging funding environment, ArriVent Biopharma has managed to secure a whopping $155 million in its Series B funding. This...

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a renowned biopharmaceutical organization dedicated to revolutionizing medicines to transform...

BioNTech has recently expanded its portfolio in the realm of cancer research and development. It has sealed a deal worth $170 million...

Pear Therapeutics, a pioneer in digital therapeutics, has recently been navigating troubled waters. This article explores the recent...

Araris Biotech AG, a frontrunner in the development of proprietary antibody-drug conjugate (ADC)-linker technology, has recently secured...

Global life sciences investor, Novo Holdings, has made a strategic investment in Alentis Therapeutics, a clinical-stage biotechnology...

Alentis Therapeutics, a biotech powerhouse known for its innovative drug research, has recently raised a whopping $105 million. This...

TORL BioTherapeutics, an emerging biopharmaceutical company, has recently made waves in the biotech industry. By successfully closing a...

Gilde Healthcare, a prominent healthcare investor, has recently announced a significant monetary commitment of €600 million towards their...

Vaxcyte, Inc. (NASDAQ: PCVX), a pioneering company specializing in the development of high-quality vaccines, recently concluded a...

AB Science, a renowned pharmaceutical company, recently marked a pivotal milestone by successfully raising €15 million via private...

Baudax Bio, Inc, a renowned pharmaceutical company with a focus on hospital-oriented products, recently triumphed in the financial market...

Araris Biotech AG, known for its pioneering antibody-drug conjugate (ADC)-linker technology, is making headlines as it receives a...

In the dynamic world of biopharmaceuticals, Annexon, Inc. (Nasdaq: ANNX) stands out as a pioneering force. The company's robust portfolio...

Gracell Biotechnologies, a leading name in the global clinical-stage biopharmaceutical industry, is on a mission to revolutionize cancer...

Genelux Corporation, a renowned name in the immuno-oncology field, has recently issued a private placement of 1,665,247 common shares....

Locanabio, a frontrunner in the genetic medicines domain, is set to receive an equity investment from CureDuchenne Ventures. This funding...

PharmEnable, a pioneer in the domain of drug discovery, has recently secured a significant investment of $7.5M in its Pre-Series A...

Quanta Therapeutics, a trailblazer in the biopharmaceutical landscape, recently announced a whopping $50.7 million Series D funding to...

7 Hills Pharma ("7HP") has made remarkable strides in the biopharmaceutical sector, recently surpassing the $25 million milestone in...